STADA invests more than EUR 50 million in new facility in Romania

STADA has taken a major step towards further strengthening its capacity to provide a reliable supply of high-quality medicines in Europe by breaking ground on a more than EUR 50 million investment in a supply-chain hub in Romania.

The supply-chain and packaging unit located in Turda, Romania, will initially house 9 state-of-the-art lines for solid-dose medicines such as tablets and capsules, with a capacity to supply 100 million packs per year. Fully-automated lines will allow multi-material packaging for a wide range of products to be supplied across Europe. An automated warehouse will have capacity for 7400 pallets, helping to strengthen security of supply.

“Developments during the pandemic, and ongoing industry challenges over the past couple of years, have demonstrated the vital importance of a robust medicines supply chain in Europe. Through this major investment, STADA is further strengthening its commitment to acting as a reliable supplier of medicines that support healthcare systems throughout Europe. By leveraging industry-leading concepts in design, construction and energy conservation, the company is also playing its part in environmental sustainability,” said STADA’s Chief Technical Officer, Miguel Pagan.

The use of environmentally-friendly packaging materials will be a key focus of the plant. Furthermore, photovoltaic solar panels and low-energy lighting will help to minimise carbon emissions. Beyond supplying essential medicines including treatments for diabetes, high cholesterol and hypertension, the new facility will generate around 375 high-quality jobs. STADA expects to commence operations at the 100 000 m2 facility in Turda’s Aries Industrial Park by the end of 2024.

Photos: STADA